The British Medical Association (BMA), the doctors' union representing thousands of physicians across the UK, has officially endorsed the findings and recommendations of the Cass Review into NHS gender identity services. In a statement released on Thursday, the BMA called for a more cautious, evidence-based approach to treating children and young people with gender dysphoria, aligning with the review's emphasis on holistic care and long-term outcome data.
Key Recommendations Supported
The BMA's backing includes support for the Cass Review's central recommendation that NHS England should establish a new model of care for children and young people experiencing gender-related distress. This model would prioritize psychological support and exploration of identity over immediate medical interventions such as puberty blockers and hormones. The union also endorsed the call for improved data collection and research to track outcomes of treatments, which has been a major gap in current practice.
Implications for NHS Practice
The BMA's position is significant because it represents the views of a large body of medical professionals who will be involved in implementing any changes. The union emphasized that care must be patient-centered and that clinicians should have the freedom to exercise clinical judgment without political interference. However, it also stressed the need for services to be adequately funded and staffed to meet demand, which has surged in recent years.
The Cass Review, published in April 2026, was commissioned by NHS England following concerns about the rapid increase in referrals to gender identity clinics and a lack of robust evidence for some treatments. The review found that many young people presenting with gender dysphoria had complex mental health needs and that a 'watchful waiting' approach was often more appropriate than immediate medical transition.
Reactions and Next Steps
While the BMA's endorsement has been welcomed by some campaigners who argue for greater caution, it has drawn criticism from transgender rights groups who fear that the recommendations could restrict access to care. The BMA has responded by stating that its priority is to ensure that all patients receive safe, effective, and compassionate treatment, and that the Cass Review provides a roadmap to achieve that.
NHS England is now expected to begin implementing the review's recommendations, with a phased rollout of new regional hubs for gender services. The BMA has pledged to work with NHS England and other stakeholders to ensure that the changes are introduced in a way that supports both patients and clinicians.
